[EN] PDE4 INHIBITORS SELECTIVE FOR THE LONG FORM OF PDE4 FOR TREATING INFLAMMATION AND AVOIDING SIDE EFFECTS<br/>[FR] INHIBITEURS DE PDE4 SÉLECTIFS POUR LA FORME LONGUE DE PDE4 POUR TRAITER UNE INFLAMMATION ET ÉVITER DES EFFETS SECONDAIRES
申请人:DECODE GENETICS EHF
公开号:WO2010059838A2
公开(公告)日:2010-05-27
The present invention relates to compounds which are inhibitors of phosphodiesterase-4 (PDE4) useful for the treatment and prevention of stroke, myocardial infarct, cardiovascular inflammatory diseases and disorders and central nervous system disorders, to compounds with a selectivity for a non-catalytic portion of PDE4, to methods of determining this selectivity.